178 related articles for article (PubMed ID: 26854265)
1. Antineoplastic agents and thrombotic microangiopathy.
Garcia G; Atallah JP
J Oncol Pharm Pract; 2017 Mar; 23(2):135-142. PubMed ID: 26854265
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic microangiopathies and antineoplastic agents.
Grangé S; Coppo P;
Nephrol Ther; 2017 Apr; 13 Suppl 1():S109-S113. PubMed ID: 28577731
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series.
Leal F; Macedo LT; Carvalheira JB
J Chemother; 2014 Jun; 26(3):169-72. PubMed ID: 24091354
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic microangiopathy, cancer, and cancer drugs.
Izzedine H; Perazella MA
Am J Kidney Dis; 2015 Nov; 66(5):857-68. PubMed ID: 25943718
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic Microangiopathy in a Patient Treated With Gemcitabine.
Nanjappa S; Singh V; Uttamchandani S; Pabbathi S
Cancer Control; 2017 Jan; 24(1):54-56. PubMed ID: 28178713
[TBL] [Abstract][Full Text] [Related]
6. Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma.
Hobeika L; Self SE; Velez JC
BMC Nephrol; 2014 Sep; 15():156. PubMed ID: 25267524
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-Associated Thrombotic Microangiopathy.
Aklilu AM; Shirali AC
Kidney360; 2023 Mar; 4(3):409-422. PubMed ID: 36706238
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine-induced thrombotic microangiopathy.
Richmond J; Gilbar P; Abro E
Intern Med J; 2013 Nov; 43(11):1240-2. PubMed ID: 24237646
[TBL] [Abstract][Full Text] [Related]
9. Influenza-induced thrombotic microangiopathy in a patient with cancer on proteasome inhibitor: a diagnostic dilemma.
Hamad CD; Hoelscher ZC; Tchakarov A; Kala J
CEN Case Rep; 2022 Aug; 11(3):321-327. PubMed ID: 34997535
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic microangiopathy with targeted cancer agents.
Blake-Haskins JA; Lechleider RJ; Kreitman RJ
Clin Cancer Res; 2011 Sep; 17(18):5858-66. PubMed ID: 21813634
[TBL] [Abstract][Full Text] [Related]
11. Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report.
Nishikubo M; Shimomura Y; Hiramoto N; Sawamura N; Yamaguchi T; Hara S; Ishikawa T
BMC Nephrol; 2021 May; 22(1):175. PubMed ID: 33980166
[TBL] [Abstract][Full Text] [Related]
12. Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Yılmaz S; Özçakar ZB; Taktak A; Kiremitçi S; Ensari A; Dinçaslan H; Yalçınkaya F
Pediatr Nephrol; 2016 Jun; 31(6):1029-32. PubMed ID: 26928310
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic microangiopathy syndromes.
Zakarija A
Cancer Treat Res; 2009; 148():115-36. PubMed ID: 19377922
[No Abstract] [Full Text] [Related]
14. A case of progressive hypertension preceding gemcitabine-associated thrombotic microangiopathy complicated by acute kidney injury and stroke.
Phelan PJ; Liew A; Magee C
Ren Fail; 2009; 31(8):743-4. PubMed ID: 19814643
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine-associated livedoid thrombotic microangiopathy with associated sclerema neonatorum-like microscopic changes.
Mir-Bonafé JM; Román-Curto C; Santos-Briz A; Cañueto J; Fernández-López E; Unamuno P
J Cutan Pathol; 2012 Jul; 39(7):707-11. PubMed ID: 22612305
[TBL] [Abstract][Full Text] [Related]
16. [Clinical efficacy of eculizumab as treatment of gemcitabine-induced thrombotic microangiopathy: A case report].
Rogier T; Gerfaud-Valentin M; Pouteil-Noble C; Taleb A; Guillet M; Noel A; Broussolle C; Sève P
Rev Med Interne; 2016 Oct; 37(10):701-704. PubMed ID: 26833144
[TBL] [Abstract][Full Text] [Related]
17. Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma.
Willemsen AE; van Herpen CM; Wesseling P; Bult P; van Laarhoven HW
Acta Oncol; 2011 Apr; 50(3):462-5. PubMed ID: 20799915
[No Abstract] [Full Text] [Related]
18. Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature.
Burns ST; Damon L; Akagi N; Laszik Z; Ko AH
Anticancer Res; 2020 Jul; 40(7):3995-4000. PubMed ID: 32620643
[TBL] [Abstract][Full Text] [Related]
19. ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy.
Bittar PG; Nickolich MS; Onwuemene OA
J Clin Apher; 2018 Jun; 33(3):423-426. PubMed ID: 28940604
[TBL] [Abstract][Full Text] [Related]
20. Chronic thrombotic microangiopathy secondary to chemotherapy for urothelial carcinoma in a patient with a history of Wegener granulomatosis.
Thomas JG; Sethi S; Norby SM
Am J Kidney Dis; 2011 May; 57(5):799-802. PubMed ID: 21411201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
